Galegenimab, designated as FHTR 2163, RG 6147, and RO 7171009, is a monoclonal antibody fragment targeting High-temperature requirement A serine peptidase 1 (HTRA1). This antibody fragment is specifically developed for the investigation of its therapeutic potential in age-related macular degeneration (AMD). Galegenimab is utilized primarily in research settings to explore the pathological mechanisms of AMD and to assess its efficacy as a potential treatment modality.
Galegenimab, designated as FHTR 2163, RG 6147, and RO 7171009, is a monoclonal antibody fragment targeting High-temperature requirement A serine peptidase 1 (HTRA1). This antibody fragment is specifically developed for the investigation of its therapeutic potential in age-related macular degeneration (AMD). Galegenimab is utilized primarily in research settings to explore the pathological mechanisms of AMD and to assess its efficacy as a potential treatment modality.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
